Abstract NADPH oxidase (NOX)-dependent reactive oxygen species (ROS) production in inflammatory cells including microglia plays an important role in demyelination and free radicalmediated tissue injury in multiple sclerosis (MS). However, the mechanism underlying microglial ROS production and demyelination remains largely unknown. The voltage-gated proton channel, Hv1, is selectively expressed in microglia and is required for NOX-dependent ROS generation in the brain. In the present study, we sought to determine the role of microglial Hv1 proton channels in a mouse model of cuprizone-induced demyelination, a model for MS. Following cuprizone exposure, wild-type mice presented obvious demyelination, decreased myelin basic protein expression, loss of mature oligodendrocytes, and impaired motor coordination in comparison to mice on a normal chow diet. However, mice lacking Hv1 (Hv1 À/À ) are partially protected from demyelination and motor deficits compared with those in wild-type mice. These rescued phenotypes in Hv1 À/À mice in cuprizone-induced demyelination is accompanied by reduced ROS production, ameliorated microglial activation, increased oligodendrocyte progenitor cell (NG2) proliferation, and increased number of mature oligodendrocytes. These results demonstrate that the Hv1 proton channel is required for cuprizone-induced microglial oxidative damage and subsequent demyelination. Our study suggests that the microglial Hv1 proton channel is a unique target for controlling NOX-dependent ROS production in the pathogenesis of MS.
Multiple sclerosis (MS) is a heterogeneous inflammatory demyelinating disease, which causes chronic neurological disability beginning in early-to-mid adult life (Hauser and Oksenberg 2006) . The cuprizone intoxication model, an established toxicant-induced chronic demyelination model, is characterized by apoptosis of primary oligodendrocytes and demyelinating lesions particularly in the corpus callosum (CC) that mimics some aspects of MS (Blakemore and Franklin 2008) . Cuprizone-induced demyelination is accompanied by overwhelming glial activation, such as microgliosis and astrogliosis (Remington et al. 2007; Gudi et al. 2011) . However, microglial function in demyelination and underlying mechanisms are not understood.
Oxidative damage from reactive oxygen species (ROS) has been reported to account for pathological features of MS, including demyelination, oligodendrocyte apoptosis, and astrocyte dysfunction (Haider et al. 2011) . Mechanistically, ROS causes damage to biological macromolecules, such as polyunsaturated fatty acids in membrane lipids, proteins, and DNA/RNA in MS lesions (Liu et al. 2001; Diaz-Sanchez et al. 2006) . Inflammation-associated oxidative burst in activated microglia and macrophages is considered to be the major source of ROS in MS (Miller et al. 2013) . Indeed, NADPH oxidase (NOX)-dependent ROS production in inflammatory cells plays an important role in demyelination and free radical-mediated tissue injury in the pathogenesis of MS (Fischer et al. 2012) . Thus, reducing NOX-related oxidative stress may represent a reasonable strategy to ameliorate axonal damage in MS lesions.
Hv1 (encoded by gene Hvcn1), a novel voltage-gated proton channel, is ideally suited to the task of charge compensation for NOX activation by sensing both voltage and pH gradients (Ramsey et al. 2006; Sasaki et al. 2006; Wu 2014b) . Deletion or inhibition of Hv1 greatly reduced NOXdependent ROS production in leukocytes and bone marrow cells (Okochi et al. 2009; Ramsey et al. 2009 ). Recently, we identified that Hv1 was selectively expressed in microglia and was required for NOX-dependent ROS generation in the brain (Wu et al. 2012) . The study showed that mice lacking Hv1 (Hv1 À/À ) were protected from NOX-mediated neuronal death and brain damage after ischemic stroke. In the present study, we investigated the role of microglial Hv1 proton channel in demyelination after cuprizone exposure and whether Hv1 is a unique target for controlling NOX-dependent ROS production in the pathogenesis of MS.
Materials and methods

Animals and cuprizone treatment
Wild-type (WT) C57BL/6 mice, CX3CR1 GFP/+ mice, Hv1 À/À mice, and Hv1 À/À -CX3CR1 GFP/+ mice were used in the present study. All mice were purchased from Jax laboratory except Hv1 À/À mice (Wu et al. 2012; Eyo et al. 2015) . Mice were used in accordance with institutional guidelines as approved by the animal care and use committee at Rutgers University. All mice were housed in a temperature and humidity-controlled environment with a 12-h lightdark cycle. The details of cuprizone demyelination model were described in our previous study (VonDran et al. 2011; Fulmer et al. 2014) . In brief, 8-week-old male mice were fed 0.2% (w/w) cuprizone (Bis(cyclohexanone)oxaldihydrazone, Sigma; St. Louis, MO, USA) combined with powdered chow or control feed for 4 weeks (Harlan Teklad). Food containing cuprizone was changed every 2 days for 4 weeks. Mice used for behavioral testing were given a cuprizone diet for 6 weeks and immediately after cuprizone withdrawal normal chow was replaced for an additional 14 days as a recovery phase.
Rotarod test
Motor co-ordination and balance were evaluated using a rotarod apparatus (Med Associates Inc, St. Albans, VT, USA), which consisted of a motor-driven rotating rod equipped with variable speeds. The mice were evaluated on the rotarod three times a day for three consecutive days with the rotation set between 8 and 80 rpm. The duration for which each animal stayed on the rod (holding time) was recorded. The data presented for motor function are means from the 9 trials from the 3 consecutive days (3 trials per day). There was no significant individual daily difference in the motor function deficit in the rotarod performance tests.
Oil red O staining
Mice were anesthetized and perfused intracardially with phosphatebuffered saline followed by 4% paraformaldehyde, and the brains were treated with graded concentrations of sucrose (15-30%) for cryoprotection. Cryosections of 15 lm thickness were generated. Since cuprizone administration causes varying degrees of demyelination within the CC (Stidworthy et al. 2003) , we chose comparable sections at approximately the same anatomical co-ordinates for staining and observed at the middle of the caudal CC, overlying the hippocampus. Frozen sections were incubated in distilled water for 1 min followed by 2 min incubation in 100% propylene glycol (Polyscientific; Bayshore, NY, USA) whereupon the sections were transferred to Oil Red O for 36 h at (20-25°C) room temperature. Sections were incubated for 1 min in 85% propylene glycol, lightly stained with hematoxylin, and mounted with gelatin mounting medium.
Immunofluorescence
For immunofluorescence staining, cryosections were incubated for 1 h in blocking buffer consisting of 5% goat serum, Tris-buffered saline (TBS), and 0.1% Triton X-100. Before staining, the fixed sections were washed three times with phosphate-buffered saline for 10 min each. The following primary antibodies were used for immunostaining: rabbit anti-glial fibrillary acidic protein (GFAP) (Chemicon, Temecula, CA, USA, 1 : 500), mouse anti-myelin basic protein (MBP) (Covance, Dedham, MA, USA, 1 : 2000) , rabbit antiIba-1 (Wako, Richmond, VA, USA, 1 : 500), mouse anti-CC1 (Abcam, Cambridge, MA, USA, 1 : 50), and mouse anti-8 hydroxyguanosine Abcam, 1 : 200) . The primary antibodies were diluted in blocking buffer, applied individually to tissue sections, and incubated overnight at 4°C after which the tissue sections were washed three times for 5 min each with TBS and were incubated for 60 min in Alexa 594-labeled goat anti-mouse antibodies (for MBP and 8-OHG antibodies) or Alexa 488-labeled goat anti-rabbit antibodies (for GFAP) at a dilution of 1 : 500. The sections were washed three times for 5 min each in TBS before further observation.
BrdU incorporation and detection
To identify the proliferation of oligodendrocyte progenitor cells (OPCs), mice were injected intraperitoneally with 200 mg/kg bromodeoxyuridine (BrdU; Sigma) at 4 and 2 h before killing (Armstrong et al. 2002) . Brain sections from BrdU-injected mice were treated to permeabilize the tissue and denature the DNA, and were then incubated overnight with the following primary antibodies: rabbit polyclonal anti-NG2 antibody (1 : 200, Chemicon) and mouse monoclonal anti-BrdU antibody (1 : 50 
Western blot
Corpus callosum (CC) samples were homogenized in lysis buffer, and the homogenates were centrifuged at 7000 g for 15 min at 4°C. The supernatants were collected and the protein concentration was determined by the Bradford method. Equal amounts of protein sample (30 lg) were separated on 10% sodium dodecyl sulfate polyacrylamide gels, transferred to polyvinylidene difluoride membranes, and blocked in 5% non-fat dry milk buffer. The membranes were then incubated with the following antibodies: rabbit anti-GFAP (Chemicon, 1 : 500), mouse anti-MBP (Covance, 1 : 2000), rabbit anti-Iba-1 (Wako, 1 : 500) diluted in blocking buffer overnight at 4°C. Rabbit anti-Glyceraldehyde 3-phosphate dehydrogenase polyclonal antibody (Sigma, 1 : 2000) was detected on immunoblots as a loading control for protein quantification. Following washes, the membranes were incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1 : 2000) at (20-25°C) room temperature for 1 h and developed with enhanced chemiluminescence detection reagents as a color substrate. The membranes were scanned at 600 dpi, and the resulting digital images were analyzed quantitatively. The integrated optical density (OD) of the signals was semi-quantified and expressed as the ratio of OD from the indicated markers to OD from Glyceraldehyde 3-phosphate dehydrogenase.
Quantifications and statistical analysis
All cell counts and intensity analyses were performed blind to the experimental treatment and data were expressed as mean AE SEM. All statistical tests were performed using GraphPad Prism (GraphPad software, La Jolla, CA, USA). The group comparison was performed with two-tailed t-test and Student-Newman-Keuls method (ANOVA). p < 0.05 were considered to be statistically significant.
Results
Hv1
À/À mice show reduced demyelination and less impaired motor co-ordination after cuprizone exposure Cuprizone intoxication causes demyelination in the brain, particularly in the CC region (Steelman et al. 2012; Gudi et al. 2014) . To study the function of microglial Hv1 proton channel in cuprizone-induced demyelination, we used Oil Red O staining to visualize lipid-rich myelin debris and compared the demyelination in WT and Hv1 knockout mice (Hv1
). In WT mice fed with cuprizone for 4 weeks, obvious demyelination in the CC with a vast amount of lipid debris was observed in comparison to mice on a normal chow diet ( Fig. 1a and b) . However, the number of deposited myelin debris was reduced in cuprizone-treated Hv1 À/À mice as compared to those in the WT group (Fig. 1b) . These The mean latency to fall in rotarod test was decreased in mice after cuprizone treatment (n = 10 mice for cuprizone treatment groups) compared with control group with saline normal chow (n = 5 mice for control groups). However, Hv1 À/À mice with cuprizone (Hv1 À/À + Cupz, n = 10 mice) performed better than WT mice (WT + Cupz, n = 10 mice). After recovery with normal chow for 2 weeks, Hv1 induced motor deficits. We also examined motor behaviors in mice at 2 weeks of recovery under normal chow after 6 weeks of cuprizone feeding. Even after 2 weeks of recovery from cuprizone treatment, Hv1 À/À mice still had better motor coordination than WT mice (Fig. 1c , p < 0.01). Therefore, the attenuation of cuprizone-induced motor deficits by Hv1 deficiency is long-lasting. Together, our results show that a deficiency in the Hv1 proton channel protected mice from cuprizone intoxication, exhibiting better functional motor recovery consistent with reduced demyelination.
Reduced microglial activation in Hv1
À/À mice after cuprizone exposure Both microgliosis and astrogliosis were closely correlated with demyelination in the cuprizone model (Remington et al. 2007; Gudi et al. 2011) . Since Hv1 is selectively expressed in microglia in the brain, the reduced demyelination and motor deficits after cuprizone intoxication in Hv1 À/À mice ( Fig. 1) could be associated with microglial activation. To test this idea, we examined the microgliosis in cuprizone-induced demyelination. Using CX3CR1 GFP/+ mice in which microglia are labeled with green fluorescent protein (GFP) (Jung et al. 2000) , we observed a massive accumulation of GFP-positive microglia in bilateral regions of the CC after 4 weeks of cuprizone. In CX3CR1 GFP/+ mice lacking Hv1, the microgliosis was attenuated as compared to the WT group after cuprizone exposure ( Fig. 2a and b) . To further quantify the degree of microglial activation, western blot analysis was performed to investigate the expression of microglial marker Iba1. Consistently, we found that the Iba1 protein expression was dramatically up-regulated in WT mice (around 5 fold) and the Iba1 up-regulation was compromised in Hv1 À/À mice after cuprizone exposure ( Fig. 2e and f, p < 0.05). Therefore, microgliosis and microglial activation after cuprizone treatment were attenuated in Hv1 À/À mice compared with WT mice.
We further analyzed astrogliosis during cuprizone-induced demyelination immunostaining and western blot using anti-GFAP, a commonly used marker for astrocytes. Under control condition with normal chow, there was no significant difference of GFAP immunostaining in the CC between WT mice and Hv1 À/À mice. After 4 weeks of cuprizone feeding, the fluorescence intensity of GFAP was markedly increased. However, there was no significant difference in astrogliosis between the Hv1 À/À and WT groups after cuprizone treatment ( Fig. 2c and d) . These results were further confirmed by western blot analysis of GFAP expression. GFAP was up-regulated in the groups exposed to cuprizone compared to their respective control group on a normal diet, but no statistical difference was observed between Hv1
À/À and WT mice ( Fig. 2e and f) . Thus, the deficiency of the Hv1 proton channel reduces microgliosis but not astrogliosis after cuprizone treatment.
Attenuated microglia-derived ROS production in the corpus callosum in Hv1 À/À mice after cuprizone exposure
Hv1 is known to be engaged in NOX-dependent ROS production in microglia (Wu et al. 2012; Wu 2014b) . Given the critical role of ROS in cuprizone-induced demyelination (Gudi et al. 2014; Praet et al. 2014) , we next tested the idea that Hv1-mediated ROS production might account for the attenuated demyelination phenotype we observed in Hv1
mice. To characterize ROS production in the CC, we used an 8-OHG antibody to detect oxidized nucleic acids resulting from cellular ROS damage (Nunomura et al. 1999) . Four weeks after cuprizone diet, the intensity of 8-OHG immunoreactive signals increased significantly in the CC compared with that in control mice ( Fig. 3a and c) . The 8-OHG signals were mainly localized in GFP + microglial cells indicating that microglia are the major ROS-producing cells in the CC after cuprizone intoxication. In Hv1 À/À mice, we found that the quantified intensity of 8-OHG immunoreactive signals and the co-localization of 8-OHG signal and GFP were substantially reduced compared with WT mice after 4 weeks of cuprizone treatment (Fig. 3c , p < 0.05). These results suggest that microglial Hv1 proton channels indeed contribute to microglial ROS production after cuprizone exposure.
Increased number of NG2 + -BrdU + cells and suppressed MBP reduction in Hv1 À/À mice after cuprizone exposure NG2 is a proteoglycan present on the OPC that increase in number in response to the cuprizone lesion and are important for remyelination after cuprizone-induced injury (Mason et al. 2000) . Recent studies showed that NG2 cell proliferation after cuprizone demyelination is sensitive to ROS damage (Husain and Juurlink 1995; Back et al. 1998) . Therefore, we wanted to evaluate the impact of Hv1 proton channel deficiency on the proliferation of NG2 cells after cuprizone treatment. To this end, NG2 immunostaining was performed to identify OPCs and BrdU incorporation was used to study cell proliferation in the CC. Consistent with previous studies (Deverman and Patterson 2012; Sachs et al. 2014) , the number of proliferating OPCs, as measured by BrdU labeling, was largely increased after 4 weeks of cuprizone treatment in WT mice ( Fig. 4a and b) . Interestingly, we found that there was a significant increase in the number of total BrdU positive cells as well as NG2-BrdU double positive cells in Hv1 À/À mice than in those in WT mice ( Fig. 4b and c, with those in WT mice may lead to enhanced remyelination and mature oligodendrocytes after cuprizone-induced injury (Mason et al. 2000) . To begin to test this idea, MBP immunoreactivity and levels were first analyzed at 4 weeks following cuprizone intoxication. Strong MBP- Summarized data showing that cuprizone-induced Iba1 increase were comprised in Hv1 À/À mice compared WT mice. Each bar is shown as a ratio of its own optical density to that of Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression (n = 3 mice for each group). *p < 0.05. positive immunostaining was observed in the CC of both WT and Hv1 À/À control groups. In the cuprizone exposure group, there was a remarkable reduction in MBP immunoreactivity ( Fig. 5a and b) . However, the cuprizone-induced MBP decrease was ameliorated in Hv1
À/À group compared to the WT group (Fig. 5a and b) . Consistently, western blot analysis confirmed that MBP expression was significantly reduced after cuprizone treatment, but the reduction was partially reversed in Hv1 À/À mice ( Fig. 5c and d, p < 0.05). In line with the ameliorated MBP reduction, we also found that there were significant more mature oligodendroctyes in Hv1 À/À mice than in WT mice after cuprizone treatment ( Fig. 5e and f, p < 0.05). Therefore, these results demonstrate a possible enhanced remyelination due to the increased number of mature oligodendrocytes in Hv1 À/À mice, suggesting that the microglial Hv1 proton channel aggravates remyelination in cuprizone intoxication. 
Discussion
In the present study, we found that Hv1 À/À mice have reduced microglial accumulation, ROS production, increased NG2 proliferation, and are partially protected from demyelination and motor deficits after cuprizone exposure. These results suggest that microglial Hv1 proton channels may promote cuprizone-induced demyelination through ROS production. Our study is the first to explore microglial Hv1 function in the pathogenesis of demyelination and extends previous evidence of oxidative injury in MS (Haider et al. 2011; van Horssen et al. 2011; Fischer et al. 2012) . Microglia, the resident hematopoietic cells in the central nervous system (CNS), participate in the regulation of immune responses due to their ability to present antigens and secrete immunoregulatory factors such as neurotrophins, chemokines, cytokines, and ROS (Voss et al. 2012; Eyo and Wu 2013) . It has been debated whether microglia play a harmful or beneficial role in demyelination/remyelination during MS. On one hand, microglia can exert neuroprotective effects through the expression of anti-inflammatory molecules, phagocytosis of debris, and tissue repair. On the other hand, there is evidence demonstrating a detrimental role for microglia. For example, mice with ablated microglia were protected in an experimental model of autoimmune enchephalomyelitis (Heppner et al. 2005) . In addition, microglia can recruit and reactivate T cells in the CNS and release many detrimental molecules such as proteases, inflammatory cytokines, and free radicals, which then contribute toxicity to bystanders like neurons and glial cells (Rawji and Yong 2013) . In line with the harmful role of microglia in the MS, we found increased microgliosis and microglial activation associated with myelin loss and OPC loss in mice after cuprizone exposure. In Hv1 À/À mice, there was attenuated microglial activation and reduced demyelination, suggesting that microglial Hv1 promotes cuprizone-induced demyelination.
Recently, several studies provided evidence for oxidative damage of oligodendrocytes and dystrophic axons in early stages of active MS lesions (Haider et al. 2011; Fischer et al. 2012) . For instance, mitochondrial pathology and focal axonal degeneration were initiated by the macrophagemediated production of reactive oxygen and nitrogen species (ROS and RNS). Neutralization of the ROS and RNS could effectively reverse axonal degeneration and thus protect tissue injury in MS (van Horssen et al. 2011) . Here, we found that 8-OHG expression, a marker of ROS, was up-regulated in activated microglia at week 4 after cuprizone diet, indicating increased ROS production after demyelination. ROS production by microglia occurred primarily by NOX activation and required the Hv1 proton channel (Wu 2014a) . Through providing compensating charge or relieving intracellular acidosis for NOX, Hv1 was coupled to NOX-dependent pH regulation, membrane depolarization, or ROS production in a variety of cells, including neutrophils (El Chemaly et al. 2010) , B cells (Capasso et al. 2010) , and eosinophils (Zhu et al. 2013) . Consistently, in Hv1 À/À mice, there was decreased ROS production in activated microglia compared with that in WT mice after cuprizone treatment. These results demonstrate that the Hv1 proton channel is critical in demyelinationassociated ROS production in microglia. Although extensive evidence implicates increased ROS production in inflammatory demyelinating diseases, the underlying mechanisms of ROS-dependent myelin loss are not yet clear. Firstly, it has been reported that ROS could directly induce the apoptosis of oligodendrocytes, thereby leading to demyelination in MS (Griot et al. 1990; Witherick et al. 2010) . Secondly, OPC such as NG2 cells appear to be significantly more sensitive to oxidative stress compared to mature oligodendrocytes (Husain and Juurlink 1995; Back et al. 1998) . Therefore, ROS may directly target NG2 cells and thus limit CNS repair and remyelination. Thirdly, ROS also exerts direct effects on the lipid and protein components of myelin through peroxidation, and degrade MBP through the production of matrix metalloproteinases (Witherick et al. 2010) . In our present study, we found that ROS was largely produced by activated microglia after cuprizone exposure through the Hv1 proton channel. In Hv1 À/À mice after cuprizone treatment, decreased ROS production was associated with attenuated demyelination shown by Oil red staining, increased proliferating NG2 cells, and suppressed MBP reduction. As cuprizone intoxication is associated with oligodendrocytes death, loss in myelin proteins as well as progenitors maturation. The rescue of reduced MBP levels or the number of mature oligodendrocytes in Hv1 À/À mice could be due to the reduction in dying oligodendrocytes, or the decrease in demyelination, or the increase in the number of BrdU + NG2 progenitor cells. Future studies are needed to dissect the exact mechanism underlying Hv1 function in cuprizone-induced MBP alterations. Nevertheless, our results indicate that the Hv1-dependent microglial ROS promotes demyelination and hinders remyelination in cuprizone-induced injury.
In summary, our current study provides a mechanistic insight into microglia-induced myelin loss after cuprizone exposure. Microglial cells produce several cytotoxic mediators, including ROS, that may contribute directly or indirectly to the selective oligodendrocyte/myelin injury and loss. We found that the microglial Hv1 proton channel promotes cuprizone-induced demyelination and reduced proliferating NG2 related remyelination through ROS production. Identification of microglial Hv1 channels as a key factor in ROS production could serve as a novel potential therapeutic target for patients with demyelinating diseases including MS.
